Transcranial electromagnetic treatment against Alzheimer's disease: Why it has the potential to trump Alzheimer's disease drug development

Journal of Alzheimer's Disease

Volumn 32, Issue 2, 2012, Pages 243-266

  Arendash, Gary W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

AD transgenic mice; amyloid ; cognitive benefits; electromagnetic treatment; mitochondrial function; neuronal activity; transcranial

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN NERVE CELL; BRAIN TEMPERATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG RESEARCH; ELECTROENCEPHALOGRAM; ELECTROMAGNETIC FIELD; HORMESIS; HUMAN; MITOCHONDRION; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; SAFETY; TEMPERATURE SENSITIVITY; TRANSCRANIAL ELECTROMAGNETIC TREATMENT; TREATMENT OUTCOME;

EID: 84867545307     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120943     Document Type: Review

References (98)

1. Gravitz L (2011) A tangled web of targets. Nature 475, S9- S11.
2. Selkoe D (2011) Resolving controversies on the path to Alzheimer's therapeutics. Nat Med 17, 1060-1065.
3. Arendash G, Millard WJ, Dunn AJ, Meyer EM (1987) Longterm neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science 238, 952-956.
4. Khachaturian Z (2011) Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 253-256.
5. Pardridge W (2009) Alzheimer's disease drug development and the problem of the blood-brain barrier. Alzheimers Dement 5, 427-432.
6. Mattson M, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60, 748- 766.
7. Galindo MF, Ikuta I, Zhu X, Casadesus G, Jord'an J (2010) Mitochondrial biology in Alzheimer's disease pathogenesis. J Neurochem 114, 933-945.
8. MullerW, Eckert A, Curz C, Eckert G, LeunerK(2010) Mitochondrial dysfunction: Common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol Neurobiol 41, 159-171.
9. Reddy P, Manczak M, Mao P, Calkins M, Reddy A, Shirendeb U (2010) Amyloid- and mitochondria in aging and Alzheimer's disease: Implications for synaptic damage and cognitive decline. J Alzheimers Dis 20, S499-S512.
10. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26, 9057-9068.
11. Manczak M, AnekondaT, Henson E, Park B, Quinn J, Reddy P (2006) Mitochondria are a direct site of A-beta accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449.
12. Eckert A, Hauptmann S, Scherping I, Rhein V, Muller-Spahn F, Gotz J, Muller W (2008) Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener Dis 5, 157-159.
13. Morais V, Strooper B (2010) Mitochondria dysfunction and neurodegenerative disorders: Cause or consequence. J Alzheimers Dis 20, S255-S263.
14. Chen JX, Yan SS (2010) Role of mitochondrial amyloid- in Alzheimer's disease. J Alzheimers Dis 20, S569-S578.
15. Landau S, Harvey D, Madison C, Koeppe R, Reiman E, Foster M, Weiner M, Jagust W (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32, 1207-1218.
16. Supnet C, Bezprozvanny I (2010) Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease. J Alzheimers Dis 20, S487-S498.
17. Adlard P, Cherny R, Finkelstein D, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith J, Periz K, Laughton K, Li Q, Charman S, Nicolazzo J, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie C, Tanzi R, Cappai R, Masters C, Barnham K, Bush A (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial A. Neuron 59, 43-55.
18. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters C,TargumS, Murdoch J,Wilson J, Ritchie C (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting A as a modifying therapy for Alzheimer's disease: A phase IIa, double-blind, randomized, placebo-controlled trial. Lancet 7, 779-786.
19. Su G, Arendash G, Kalaria N, Bjugstad K, Mullan M (1999) Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells, and induce peripheral hemorrhage. Brain Res 818, 105- 117.
20. Nardone R, Bergmann J, Christova M, Caleri F, Tezzon F, Ladurner G, Trinka E, Golaszewshi S (2012) Effect of transcranial magnetic stimulation for the treatment of Alzheimer's Disease: A review. Int J Alzheimers Dis 2012, 687909.
21. Tufail Y, Yoshihiro A, Pati S, Li M, Tyler W (2011) Ultrasonic neuromodulation by brain stimulation with transcranial ultrasound. Nat Protocols 6, 1453-1470.
22. Arendash G, Sanchez-Ramos J, Mori T, Mamcarz M, Lin X, Runfeldt M, Wang L, Zhang G, Sava V, Tan J, Cao C (2010) Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's mice. J Alzheimers Dis 19, 191-210.
23. Arendash G, Mori T, DorseyM, Gonzalez R, Tajiri N, Borlongan C (2012) Electromagnetic treatment to old Alzheimer's mice reverses -amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit. Plos ONE 7, e35751.
24. Dragicevic N, Bradshaw P, Mamcarz M, Lin X, Wang L, Cao C, Arendash G (2011) Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: A mechanism for electromagnetic field-induced cognitive benefit? Neuroscience 185, 135-149.
25. Mori T, Arendash G (2011) Long-term electromagnetic field treatment increases brain neuronal activity: Linkage to cognitive benefit and therapeutic implications for Alzheimer's Disease. J Alzheimers Dis Parkinsonism 1, 102.
26. Arns M, Luijtelaar G, Sumich A, Hamilton R, Gordon E (2007) Electroencephalographic, personality, and executive function measures associated with frequent mobile phone use. Int J Neurosci 117, 1341-1360.
27. Schuz J, Waldemar G, Olsen J, Johansen C (2009) Risks for central nervous system diseases among mobile phone subscribers: A Danish retrospective cohort study. Plos One 4, e4389.
28. Sobel E, Davanipour Z, Qian Z, Chui H (1996) Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure. Neurology 47, 1477-1481.
29. Garcia A, Sisternas A, Perez Hoyos S (2008) Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: A meta-analysis. Int J Epidemiology 37, 329-340.
30. Hardell L, Carberg M, Hansson-Mild K (2005) Case-controlstudy on cellular and cordless telephones and the risk for acoustic neuroma or meningioma in patients diagnosed 2000-2003. Neuroepidemiology 25, 120-128.
31. Hardell L, CarlbergM, Hansson-Mild K (2006) Case-control study of the association between the use of cellular and cordless telephones and malignant brain tumors diagnosed during 2000-2003. Environ Res 100, 232-241.
32. Chou C, Guy A, Kunz L, Johnson R, Crowley J (1992) Long-term, low-level microwave irradiation of rats. Bioelectromagnetics 13, 469-496.
33. Lai H, Singh N (1995) Acute low-intensity microwave exposure increases DNA single-strand breaks in rat brain cells. Bioelectromagnetics 16, 207-210.
34. Takashima Y, Hirose H, Koyama S, Suzuki Y, Taki M, Miyakoshi J (2006) Effects of continuous and intermittent exposure to RF fields with a wide range of SARs on cell growth, survival, and cell cycle distribution. Bioelectromagnetics 27, 392-400.
35. Valberg P, van Deventer T, Repacholi M (2007) Workgroup report: Base stations and wireless networks-radiofrequency (RF) exposures and health consequences. Environ Health Perspect 115, 416-424.
36. Krewski D, Glickman B, Habash R, Habbick B, LotzW, Mandeville R, Prato F, Salem T,WeaverD(2007) Recent advances in research on radiofrequency fields and health: 2001-2003. J Toxicol Environ Health 10, 287-318.
37. Juutilainen J, Hoyto A, Kumlin T, Naarala J (2011) Review of possible modulation-dependent biological effects of radiofrequency fields. Bioelectromagnetics 32, 511-534.
38. Kwon M, Hamalainen H (2011) Effects of mobile phone electromagnetic fields: Critical evaluation of behavioral and neurophysiological studies. Bioelectromagnetics 32, 253- 272.
39. INTERPHONEStudy Group (2010) Brain tumour risk in relation to mobile telephone use: Results of the INTERPHONE international case-control study. Int J Epidemiol 39, 675-694.
40. Swerdlow A, Feychting M, Green A, Kheifets L, Savitz D, International Commission for Non-Ionizing Radiation Protection Standing Committee on Epidemiology (2011) Mobile phones, brain tumors, and the Interphone Study: Where are we now? Environ Health Perspect 119, 1534-1538.
41. Aydin D, Feychting M, Schuz J, Tynes T, Andersen T, Schmidt L, Poulsen A, Johansen C, Prochazka M, Lannering B, Klaeboe L, Eggen T, Jenni D, Grotzer M, Von derWeid N, Kuehni C, Roosli M (2011) Mobile phone use and brain tumors in children and adolescents: A multicenter case-control study. J Natl Cancer Inst 103, 1-13.
42. Frei P, Poulsen A, Johansen C, Olsen J, Steding-Jessen M, Schuz J (2011) Use of mobile phones and risk of brain tumours: Update of Danish cohort study. BMJ 343, 6387.
43. Barth A, Ponocny I, Gnambs T,Winker R (2011) No effects of short-term exposure to mobile phone electromagnetic fields on human cognitive performance: A meta-analysis. Bioelectromagnetics, 33, 159-165.
44. Besset A, Espa F, Dauvilliers Y, Billiard M, de Seze R (2005) No effect on cognitive function from daily mobile phone use. Bioelectromagnetics 26, 102-108.
45. Fritzer G, Goder R, Friege L, Wachter J, Hansen V, Hinze- Selch D, Aldenhoff J (2007) Effects of short- and long-term pulsed radiofrequency electromagnetic fields on night sleep and cognitive functions in healthy subjects. Bioelectromagnetics 28, 316-325.
46. Huber R,TreyerV, Schuderer J, BertholdT, Buck A,Kuster N, Landolt H, Achermann P (2005) Exposure to pulse-modulated radio frequency electromagnetic fields affects regional cerebral blood flow. Eur J Neurosci 21, 1000-1006.
47. Aalto S, Haarala C, Bruck A, Sipila H, Hamalainen H (2006) Mobile phone affects cerebral blood flow in humans. J Cereb Blood Flow Metab 26, 885-890.
48. Volkow N, Tomasi D, Wang G, Vaska P, Fowler J, Telang F, Alexoff D, Logan J, Wong C (2011) Effects of cell phone radiofrequency signal exposure on brain glucose metabolism. JAMA 305, 808-813.
49. Lai H, Horita A, Guy A (1994) Micorwave irradiation affects radial-arm maze performance in the rat. Bioelectromagnetics 15, 95-104.
50. Wang B, Lai H (2000) Acute exposure to pulsed 2450-MHz microwaves affects water-maze performance of rats. Bioelectromagnetics 21, 52-56.
51. Cobb B, Jauchem J, Adair E (2004) Radial arm maze performance of rats following repeated low level microwave radiation exposure. Bioelectromagnetics 25, 49-57.
52. Cassel J, Cosquer B, Galani R, Kuster N (2004) Whole-body exposure to 2.45 GHz electromagnetic fields does not alter radial-maze performance in rats. Behav Brain Res 155, 37-43.
53. Cosquer B, Kuster N, Cassel J-C (2005) Whole-body exposure to 2.45 GHz electromagnetic fields does not alter 12-arm radial-maze with reduced access to spatial cues in rats. Behav Brain Res 161, 331-334.
54. Liu T, Wang S, He L, Ye K (2008) Chronic exposure to low-intensity magnetic field improves acquisition and maintenance of memory. NeuroReport 19, 549-552.
55. Sienkiewicz Z, Blackwell R, Haylock R, Saunders R, Cobb B (2000) Low-level exposure to pulsed 900MHz microwaveradiation does not cause deficits in the performance of a spatial learning task in mice. Bioelectromagnetics 21, 151-158.
56. Fragopoulou A, Mitiadous P, Stamatakis A, Stylianopoulou F, Koussoulakos S, Margaritis L (2010) Whole body exposure with GSM 900MHz affects spatial memory in mice. Pathophysiology 17, 179-187.
57. Nittby H, Grafstrom G, Tian D, Malmgren L, Brun A, Persson B, Salford S, Eberhardt J (2008) Cognitive impairment in rats after long-term exposure to GSM-900 mobile phone radiation. Bioelectromagnetics 29, 219-232.
58. Kumlin T, Iivonen H, Miettinen P, Juvonen A, Groen T, Puranen L, Pitkaaho R, Juutilainen J, TanilaH(2007) Mobil phone radiation and the developing brain: Behavioral and morphological effects in juvenile rats. Radiation Res 168, 471-479.
59. Dubreuil D, Jay T, Edeline J (2002) Does head-only exposure to GSM-900 electromagnetic fields affect the performance of rats in spatial learning tasks? Behav Brain Res 129, 203- 210.
60. Dubreuil D, Jay T, Edeline M (2003) Head-only exposure to GSM 900-MHz electromagnetic fields does not alter rat's memory in spatial and non-spatial tasks. Behav Brain Res 145, 51-61.
61. Ammari M, Jacquet A, Lecomte A, Sakly M, Abdelmelek H, de Seze R (2008) Effect of head-only sub-chronic and chronic exposure to 900-MHz GSM electromagnetic fields on spatial memory in rats. Brain Injury 22, 1021-1029.
62. Garcia M, Gordon M, Hutton M, Lewis J, McGowan E, Dickson D,Morgan D, ArendashG(2004) The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer's transgenic mice. NeuroReport 15, 73-77.
63. Ethell D, Shippy D, Cao C, Cracchiolo J, Arendash G (2006) Adoptive transfer of A-specific T-cells reverses cognitive decline and synaptic loss in Alzheimer's transgenic mice. Neurobiol Dis 23, 351-361.
64. Arendash G, SchleifW, Rezai-Zadeh K, Jackson E, Zacharia L, Cracchiolo J, Shippy D, Tan J (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain A production. Neuroscience 142, 941-952.
65. Arendash G, Jensen M, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, PotterH(2007)Adiet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience 149, 286-302.
66. Cracchiolo J, Mori T, Bachstetter A, Mervis R, Nazian S, Tan J, Potter H, Arendash G (2007) Enhanced cognitive activity - over and above social or physical activity - is required to protect Alzheimer's mice against cognitive impairment, reduce A deposition, and increase synaptic area. Neurobiol Learn Mem 88, 277-294.
67. Echeverria V, Burgess S, Gamble-George J, Zeitlin R, Lin X, Cao C, Arendash G (2009) Sorafenib inhibits NF-kB, decreases iNOS and Cox-2 expression, and restores working memory in APPswe mice. Neuroscience 162, 1220-1231.
68. Loewenstein D, Acevedo A, Luis C, Crum T, BarkerW, Duara R (2004) Semantic interference deficits and the detection of mild Alzheimer's disease and mild cognitive impairment without dementia. J Int Neuropsychol Soc 10, 91-100.
69. Belyaev I,Koch C,Terenius O, Roxstrom-Lindquist K, Malmgren L, Sommer W, Salford L, Persoon B (2006) Exposure of rat brain to 915MHz GSM microwaves induces changes in gene expression but not double stranded DNA breaks or effects on chromatin conformation. Bioelectromagnetics 27, 295-306.
70. Perez F, Zhou X, Morisaki J, Jurivich D (2008) Electromagnetic field therapy delays cellular senescence and death by enhancement of the heat shock response. Exp Gerontol 43, 307-316.
71. Cohen E, Bieschke J, Perciavalle R, Kelly J, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity. Science 313, 1604-1610.
72. Soderqvist F, Hardell L, CarlbergM, Hansson Mild K (2010) Radiofrequency fields, transthyretin, and Alzheimer's disease. J Alzheimers Dis 20, 599-606.
73. Buxbaum J, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, Masliah E, Roberts A, Bartfai T (2008) Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of A toxicity. Proc Natl Acad Sci U S A 105, 2681- 2686.
74. Han S-H, Jung E, Sohn J-H, Hong H, Kim J, Lyul D, Kim M, Kim H, Ha H, Kim Y, Huh N, Jung M, Mook-Jung I (2011) Human serum transthyretin levels correlate inversely with Alzheimer's disease. J Alzheimers Dis 25, 77-84.
75. Hansson S, Andreasson U, Wall M, Skoog I, Andreasen N, Wallin A, Zetterberg H, Blennow K (2009) Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients. J Alzheimers Dis 16, 389-397.
76. Olcese J, Cao C, Mori T, Mamcarz M, Maxwell A, Runfeldt M, Wang L, Zhang C, Lin X, Zhang G, Arendash G (2009) Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 47, 82-96.
77. Echeverria V, Zeitlin R, Burgess S, Barman A, Thakur G, Mamcarz M, Wang W, Sattelle D, Kirschner D, Mori T, Leblanc R, Prabhakar R, ArendashG(2011) Cotinine reduces amyloid- aggregation and improves memory in Alzheimer's disease mice. J Alzheimers Dis 24, 817-835.
78. Ito S, Ohtsuki S, Kamiie J, Nezu Y, Terasaki T (2007) Cerebral clearance of human amyloid- peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein- 1 ligand complexes. J Neurochem 103, 2482-2490.
79. Imbimbo B (2008) Therapeutic potential of gamma-secretase inhibitors and modulators. Cur Top Med Chem 8, 54-61.
80. Meyer-Luehmann M, Mielke M, Spires-Jones T, Stoothoff W, Jones P, Bacskai B, Hyman B (2009) A reporter of local dendritic translocation shows plaque-related loss of neural system function in APP-transgenic mice. J Neurosci 29, 1236- 1240.
81. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz K, Jendrach M, Leuner K, Eckert A, MullerW(2008) Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30, 1574-1586.
82. Dragicevic N, Mamcarz M, ZhuY, Buzzeo R, Tan J, Arendash G, Bradshaw P (2010) Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimers Dis 20, S535- S550.
83. Jaqust W, Landau S, Shaw L, Trojanowski J, Koeppe R, Reiman E, Foster N, Petersen R, Weiner M, Price J, Mathis C (2009) Relationships between biomarkers in aging and dementia. Neurology 73, 1193-1199.
84. Zhang J, Zhang D, McQuade J, Behbehani M, Tsien J, Xu M (2002) c-fos regulates neuronal excitability and survival. Nat Genet 30, 416-420.
85. Stone S, Teixeira C, DeVito L, Zaslavsky K, Josselyn S, Lozano A, Frankland P (2011) Stimulation of entorhinalcortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci 31, 13469-13484.
86. Cuccurazzu B, Leone L, Podda M, Piacentini R, Riccardi E, Ripoli C, Azzena G, Grassi C (2010) Exposure to extremely low-frequency (50 Hz) electromagnetic fields enhances adult hippocampal neurogenesis in C57BL/6 mice. Exp Neurol 226, 173-182.
87. Cirrito J, Yamada K, Finn M, Sloviter R, Bales K, May P, Schoepp D, Paul S, Mennerick S, HoltzmanD(2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913-922.
88. Perez F, Zhou X, Moriasaki J, Ilie J, JamesT, JurivichD(2008) Engineered repeated electromagnetic field shock therapy for cellular senescence and age-related diseases. Rejuvenation Res 11, 1049-1057.
89. Rattan S (2004) Aging intervention, prevention, and therapy through hormesis. J Gerontol Biol Sci Med Sci 59, 705-709.
90. Osera C, Fassina L, Amadio M, Venturini L, Buoso E, Magenes G, Govoni S, Ricevuti G, PascaleA(2011) Cytoprotective response induced by electromagnetic stimulation on SH-SY5Y human neuroblastoma cell line. Tissue Eng Part A 17, 2573-2582.
91. Salford L, Brun A, Eberhardt J, Malmgren L, Persson B (2003) Nerve cell damage in mammalian brain after exposure to microwaves from GSM mobile phones. Environ Health Perspect 111, 881-883.
92. Grafstrom G, Nittby H, Brun A, Malmgren L, Persson B, Salford L, Eberhardt J (2008) Histopathological examinations of rat brains after long-term exposure to GSM-900 mobile phone radiation. Brain Res Bull 77, 257-263.
93. Van Leeuwen G, Lagendijk J, Van Leersum B, Zwamborn A, Hornsleth S, Kotte A (1999) Calculation of change in brain temperatures due to exposure to a mobile phone. Phys Med Biol 44, 2367-2379.
94. Masuda H, Hirata A, Kawai H, Wake K, Watanabe S, Arima T, Poulletier de Gannes F, Lagroye I, Veyret B (2011) Local exposure of the rat cortex to radiofrequency electromagnetic fields increases local cerebral blood flow along with temperature. J Appl Physiol 110, 142-148.
95. Haarala C, Aalto S, Hautzel H, Julkunen L, Rinne J, Laine M, Krause B, Hamalainen H (2003) Effects of a 902MHz mobile phone on cerebral blood flowin humans:APET study. Neuroreport 14, 2019-2023.
96. Nybo L, Moller K, Volianitis S, Nielsen B, Secher N (2002) Effects of hyperthermia on cerebral blood flow and metabolism during prolonged exercise in humans. J Appl Physiol 93, 58-64.
97. Nelson M, Haykowsky M, Stickland M, Altamirano-Diaz L, Willie C, Smith K, Petersen S, Ainslie P (2011) Reductions in cerebral blood flow during passive heat stress in humans: Partitioning the mechanisms. J Physiol 589, 4053-4064.
98. Ikonomovic M, Uryu K, Abrahamson E, Ciallella J, Trojanowski J, LeeV, Clark R, Marion D,Wisniewski S,DeKosky S (2004) Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 190, 192-203